Asset Management One Co. Ltd. Has $73,000 Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Asset Management One Co. Ltd. decreased its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 97.7% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,054 shares of the medical instruments supplier's stock after selling 87,781 shares during the quarter. Asset Management One Co. Ltd.'s holdings in DENTSPLY SIRONA were worth $73,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of XRAY. VisionPoint Advisory Group LLC lifted its stake in shares of DENTSPLY SIRONA by 104.2% in the 3rd quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier's stock valued at $26,000 after purchasing an additional 395 shares during the period. Point72 Asset Management L.P. acquired a new position in shares of DENTSPLY SIRONA in the 2nd quarter valued at $44,000. Parkside Financial Bank & Trust lifted its stake in shares of DENTSPLY SIRONA by 163.7% in the 1st quarter. Parkside Financial Bank & Trust now owns 915 shares of the medical instruments supplier's stock valued at $46,000 after purchasing an additional 568 shares during the period. Anchor Investment Management LLC acquired a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at $47,000. Finally, Exchange Traded Concepts LLC lifted its stake in shares of DENTSPLY SIRONA by 41.2% in the 3rd quarter. Exchange Traded Concepts LLC now owns 1,504 shares of the medical instruments supplier's stock valued at $51,000 after purchasing an additional 439 shares during the period. Institutional investors and hedge funds own 95.70% of the company's stock.

DENTSPLY SIRONA Stock Down 1.3 %

XRAY stock traded down $0.41 during trading hours on Monday, reaching $30.89. 2,819,624 shares of the stock were exchanged, compared to its average volume of 3,473,273. The company has a market cap of $6.41 billion, a price-to-earnings ratio of -49.82, a PEG ratio of 1.27 and a beta of 0.98. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.38 and a quick ratio of 0.95. DENTSPLY SIRONA Inc. has a 12 month low of $26.27 and a 12 month high of $43.24. The firm's 50-day moving average is $33.03 and its 200-day moving average is $32.92.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its quarterly earnings results on Thursday, February 29th. The medical instruments supplier reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.01. DENTSPLY SIRONA had a negative net margin of 3.33% and a positive return on equity of 11.14%. The firm had revenue of $1.01 billion for the quarter, compared to analysts' expectations of $972.61 million. During the same period in the prior year, the firm earned $0.46 EPS. The business's revenue was up 3.0% on a year-over-year basis. On average, equities research analysts expect that DENTSPLY SIRONA Inc. will post 2.05 earnings per share for the current year.

DENTSPLY SIRONA Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, April 12th. Shareholders of record on Friday, March 29th were given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.07%. The ex-dividend date of this dividend was Wednesday, March 27th. This is a positive change from DENTSPLY SIRONA's previous quarterly dividend of $0.14. DENTSPLY SIRONA's dividend payout ratio is presently -103.22%.

Analyst Ratings Changes

A number of research firms have recently weighed in on XRAY. Needham & Company LLC reissued a "buy" rating and issued a $42.00 price target on shares of DENTSPLY SIRONA in a research note on Thursday, February 29th. Barrington Research reaffirmed an "outperform" rating and set a $41.00 price objective on shares of DENTSPLY SIRONA in a research note on Friday, March 1st. StockNews.com raised DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research note on Friday, January 19th. Leerink Partnrs reaffirmed an "outperform" rating on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. Finally, SVB Leerink began coverage on DENTSPLY SIRONA in a research note on Monday, February 26th. They set an "outperform" rating and a $42.00 price objective on the stock. Three analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, DENTSPLY SIRONA has a consensus rating of "Moderate Buy" and a consensus price target of $39.50.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.